India, Nov. 25 -- Caring Cross, a US-based non-profit dedicated to expanding global access to advanced therapies, has announced a new partnership with the Amrita Research Center Delhi (ARCD) and Amrita Vishwa Vidyapeetham, a leading multi-campus, research-intensive university in India.

Together, the organisations will develop and implement affordable, scalable cell and gene therapy (CGT) solutions to treat diseases affecting underserved communities, particularly Sickle Cell Disease, Thalassemia, and various cancers.

Cell and gene therapies have emerged as transformative medical innovations capable of curing or significantly improving the outcomes of previously incurable diseases. However, their exceptionally high cost has limited their ...